Trial intelligence / Profile preview

JAK inhibitor effects on intestinal immune-cell networks in ulcerative colitis

NL-OMON51787Not yet recruiting

Sponsor
Leiden University Medical Center
Start
Dec 2022
Countries
1
01

Overview

Open-label, single-arm trial in autoimmune colitis, sponsored by Leiden University Medical Center. Planned start Dec 2022; status: not yet recruiting.

02

Conditions

autoimmune colitis

Beyond the preview

Go deeper on NL-OMON51787.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON51787.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call